It’s that time of the year to sign up for the 3rd annual Dynamic Wedge Golf Tournament Presidio Golf on Sunday 9/28/2025. Join us for a great time w your #radonc colleagues! Early bird special is available until 8/1. Sign up here today! koreanastro.org/golf-tournamen… #ASTRO25

Led by Drs. Zakeri & Nancy Lee, we report early Memorial Sloan Kettering Radiation Oncology exp w/ 40 Gy ENI + CCRT for larynx, HPX, p16- OPX + CUP, 97.3% platinum, no uninvolved 1B+5 ☑️73 pts, f/u 23 months ✅no solitary elective failures, all LRF include 70 Gy failures ✅good QoL 👉 shorturl.at/CKA6W

We are accepting articles for this special call now!

Did you know you can donate blood in honor of an MD Anderson Cancer Center patient? If they don't need🩸, they get an honorarium credited to their account. I'm giving platelets today in honor of one of my pts. Talk about immediately reducing #financialToxicity in small but measurable ways!

In Journal of Clinical Oncology, our reflections on the timely ASCO TORS guideline Nancy Lee Nadeem Riaz 💡Encourage MR (r/o T4+ENE) & PET (r/o contra in N+) 💡Promote ND qual (min # nodes), ⬇️ bilat ND (morbid) 💡Caution re: ❌chemo 2/2 ENE degree & real-world use of frozens re margin status

🚨 The FDA has approved the immunotherapy drug #pembrolizumab (Keytruda®) to be given before and after surgery for patients with #headandneck squamous cell cancer (#HNSCC) in combination with standard therapy. Dr. Nancy Lee, a radiologist oncologist at MSK, helped design the

Thrilled to share our impact factor is rising and the highest it’s been since inception! Special thanks to our editors, editorial staff, and most of all, our readership and contributors to the journal!!! #ASTRO

Looking ahead to #ASTRO25, we encourage everyone to join the first ever KoreanASTRO-KOSRO session where we will hear/discuss RT for neurodegen dz, OA and vtach. Session will be Tuesday morning at 8am. See you then, bright and early!

👋Congrats on this comprehensive guideline, a tremendous global effort! Primary target volume delineation for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas - The Lancet Oncology thelancet.com/journals/lanon…

If you missed the informative talk by Susan Wu on the indications for RT in leukemia make sure you catch it on demand! #ASTRO25 ILROG Team Bouthaina Dabaja MD Jillian Gunther Penny Fang

Thank you to ASTRO and the entire staff including Jeff White for welcoming children to the meeting. Makes it a little bit easier for working parents!

Come at 8 am Tuesday for our historic KASTRO/KOSRO educational session (Room 314) at ASTRO for international perspectives on expanding the role of RT for nonmalignant disease! Also let me know if interested in KASTRO annual dinner at 6 pm Tuesday at American Bookbinders Museum!

Anna Lee ASTRO Uncle Jeff was so happy to see you all!

#ASTRO25 Speed Mentoring session w Anna Lee. ASTRO MD Anderson Cancer Center

🚨TOROEDO trial - superbly executed with uniform RT plan QA/no crossover. No difference in either endpoints. What’s next? Refine the strategy. Technology is a means to an end. Reduce volume and dose (gross/elective) with biology based therapy selection. ASTRO #astro25

We are excited to announce that Xiaojing Huang, MD, PhD has joined the clinical faculty as an Assistant Professor @UMNMed. As a physician-scientist, Dr. Huang will be providing clinical coverage at UMMC, treating breast malignancies. Welcome!

Let’s gooooo! Congrats to my dear friend Dr. C Dave Fuller on his Fellow of ASTRO designation. 💪🏾💪🏾#ASTRO25 MD Anderson Cancer Center

Congratulations Rachel Jimenez, MD and the class of #ASTRO25 Fellows!! ASTRO

I think we need to reserve judgement and final analysis until seeing all of the papers from these trials…. … but are these results really so different? - In the US trial, more IMRT patients (40% vs. 27% = 13% difference) received g-tubes. - In the UK trial, more IMRT patients